1. A new paradigm of vitamin K action
   Toshio OKANO, 2017, Japanese Journal of Thrombosis and Hemostasis CrossRef
2. Key Pathways and Regulators of Vitamin K Function and Intermediary Metabolism
   Martin J. Shearer et al, 2018, Annual Review of Nutrition CrossRef
3. Efficacy of Ezetimibe Is Not Related to NPC1L1 Gene Polymorphisms in a Pilot Study of Chilean Hypercholesterolemic Subjects
   Tomás Zambrano et al, 2015, Molecular Diagnosis & Therapy CrossRef
4. Genetic variations of the NPC1L1 gene associated with hepatitis C virus (HCV) infection and biochemical characteristics of HCV patients in China
   A.-Mei Zhang et al, 2016, International Journal of Infectious Diseases CrossRef
5. Association between the use of lipid‐lowering drugs and the risk of inflammatory bowel disease
   Xuxu Liu et al, 2023, European Journal of Clinical Investigation CrossRef
6. A New Horizon in Vitamin K Research
   Toshio Okano, 2016, YAKUGAKU ZASSHI CrossRef
7. Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
   Jiaxi Zhao et al, 2024, Diabetology & Metabolic Syndrome CrossRef